Functional Nucleic Acid Nanostructures for Mitochondrial Targeting: The Basis of Customized Treatment Strategies
Wanchong He,
No information about this author
Siyu Dong,
No information about this author
Qinghua Zeng
No information about this author
et al.
Molecules,
Journal Year:
2025,
Volume and Issue:
30(5), P. 1025 - 1025
Published: Feb. 24, 2025
Mitochondria,
as
vital
organelles,
play
a
central
role
in
subcellular
research
and
biomedical
innovation.
Although
functional
nucleic
acid
(FNA)
nanostructures
have
witnessed
remarkable
progress
across
numerous
biological
applications,
strategies
specifically
tailored
to
target
mitochondria
for
molecular
imaging
therapeutic
interventions
remain
scarce.
This
review
delves
into
the
latest
advancements
leveraging
FNA
mitochondria-specific
cancer
therapy.
Initially,
we
explore
creation
of
FNA-based
biosensors
localized
mitochondria,
enabling
real-time
detection
visualization
critical
molecules
essential
mitochondrial
function.
Subsequently,
examine
developments
aimed
at
mitochondrial-targeted
treatments,
including
modular
nanodevices
precise
delivery
agents
programmable
disrupting
processes.
Emphasis
is
placed
on
elucidating
chemical
principles
underlying
design
mitochondrial-specific
nanotechnology
diverse
uses.
Lastly,
address
unresolved
challenges
outline
prospective
directions,
with
goal
advancing
field
encouraging
sophisticated
tools
both
academic
inquiry
clinical
applications
centered
mitochondria.
Language: Английский
Programmable Split DNAzyme Modulators via Allosteric Cooperative Activation for mRNA Electrochemiluminescence Biosensing
Liu-Qing Tan,
No information about this author
Weijia Zeng,
No information about this author
Qiaolin Chen
No information about this author
et al.
Analytical Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 3, 2025
DNAzymes,
known
for
their
programmability,
stability,
and
cost-effectiveness,
are
powerful
tools
signal
transduction
in
complex
biological
systems.
However,
application
responding
to
target
effectors
is
often
hindered
by
limited
catalytic
efficiency
susceptibility
unintended
activation.
Here
we
propose
an
allosteric
cooperative
activation
strategy
program
a
split
DNAzyme
modulator
(STATER)
that
enables
sensitive
accurate
electrochemiluminescence
(ECL)
biosensing
of
interleukin-6
(IL-6)
mRNA.
Our
design
features
STATER
leverages
DNA
tetrahedron
as
central
scaffold,
equipped
with
two
pairs
T-shaped
hairpin
probes
(TP)
helper
(HP).
Specifically,
the
TP
contains
apurinic/apyrimidinic
endonuclease
1
(APE1)
recognition
sites,
IL-6
mRNA
region,
partzyme
fragment,
while
HP
corresponding
paired
fragment.
Unlike
conventional
modulators
rely
on
single
effector
activation,
integrates
mechanism,
which
ensures
all
preblocked
components
synergistically
activated
assembled
within
confined
space,
facilitating
rapid
specific
reconstruction
DNAzyme's
active
domain.
Furthermore,
upon
APE1
mRNA,
inactive
partzymes
undergo
assembly
via
toehold
exchange
displacement
reaction,
switching
cleavage
reactivity
STATER.
This
mechanism
establishment
threshold
thereby
minimizing
nonspecific
scenarios.
studies
demonstrate
exhibits
outstanding
sensitivity
selectivity
detection
using
supramolecular
gold
nanoclusters
network-based
ECL
platform.
The
biosensor
provides
linear
span
from
×
10–13
10–7
M,
limit
low
3.26
10–14
highlighting
STATER's
potential
detecting
various
analytes
Language: Английский